The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000527.5(LDLR):c.1323C>G (p.Ile441Met)

CA10585401

251784 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: e2c545fd-bde0-4a3b-98d9-d3ced9f509bf
Approved on: 2022-01-17
Published on: 2022-07-12

HGVS expressions

NM_000527.5:c.1323C>G
NM_000527.5(LDLR):c.1323C>G (p.Ile441Met)
NC_000019.10:g.11113414C>G
CM000681.2:g.11113414C>G
NC_000019.9:g.11224090C>G
CM000681.1:g.11224090C>G
NC_000019.8:g.11085090C>G
NG_009060.1:g.29034C>G
ENST00000558518.6:c.1323C>G
ENST00000252444.9:n.1577C>G
ENST00000455727.6:c.819C>G
ENST00000535915.5:c.1200C>G
ENST00000545707.5:c.942C>G
ENST00000557933.5:c.1323C>G
ENST00000558013.5:c.1323C>G
ENST00000558518.5:c.1323C>G
ENST00000559340.1:n.44C>G
ENST00000560173.1:n.322C>G
ENST00000560467.1:n.803C>G
NM_000527.4:c.1323C>G
NM_001195798.1:c.1323C>G
NM_001195799.1:c.1200C>G
NM_001195800.1:c.819C>G
NM_001195803.1:c.942C>G
NM_001195798.2:c.1323C>G
NM_001195799.2:c.1200C>G
NM_001195800.2:c.819C>G
NM_001195803.2:c.942C>G

Uncertain Significance

Met criteria codes 3
PM5 PM2 PP3
Not Met criteria codes 18
BA1 PM3 PM1 PM4 PM6 BS4 BS3 BS1 BP2 BP4 BP7 PVS1 PS2 PS4 PS3 PS1 PP4 PP1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1323C>G (p.Ile441Met) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying evidence codes (PM2, PP3 and PM5) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: PM2 - This variant is absent from gnomAD (gnomAD v2.1.1), so PM2 is Met. PP3 - REVEL = 0.769. It is above 0.75, so PP3 is Met. PM5 - 2 other missense variants in the same codon: - NM_000527.5(LDLR):c.1322T>C (p.Ile441Thr) (ClinVar ID: 251783) - Pathogenic by these guidelines - NM_000527.5(LDLR):c.1322T>A (p.Ile441Asn) (ClinVar ID: 251782) - VUS by these guidelines There is 1 variant in the same codon classified as Pathogenic by these guidelines, so PM5 is Met.
Met criteria codes
PM5
2 other missense variants in the same codon: - NM_000527.5(LDLR):c.1322T>C (p.Ile441Thr) (ClinVar ID: 251783) - Pathogenic by these guidelines - NM_000527.5(LDLR):c.1322T>A (p.Ile441Asn) (ClinVar ID: 251782) - VUS by these guidelines There is 1 variant in the same codon classified as Pathogenic by these guidelines, so PM5 is Met.
PM2
This variant is absent from gnomAD (gnomAD v2.1.1), so PM2 is Met.
PP3
REVEL = 0.769. It is above 0.75, so PP3 is Met.
Not Met criteria codes
BA1
No population data was found for this variant in gnomAD (gnomAD v2.1.1), so BA1 is Not Met.
PM3
Not observed in trans with other LP/P variants, so PM3 is Not Met.
PM1
Variant meets PM2 but is not located in exon 4 or alters a cysteine residues, so PM1 is Not Met.
PM4
Variant meets PM2 and is missense, so PM4 is Not Met.
PM6
de novo occurrence data not reported, so PM6 is Not Met.
BS4
Lack of segregation data not reported, so BS4 is Not Met.
BS3
Functional studies are performed in compound heterozygous patients cells, so BS3 is not applicable.
BS1
No population data was found for this variant in gnomAD (gnomAD v2.1.1), so BS1 is Not Met.
BP2
Not observed in trans with other LP/P variants, so BP2 is Not Met.
BP4
REVEL = 0.769. It is not below 0.50, so BP4 is Not Met.
BP7
Variant is not synonymous, so BP7 is Not Met.
PVS1
Variant is missense, so PVS1 is Not Met
PS2
de novo occurrence data not reported, so PS2 is Not Met.
PS4
Variant meets PM2, but data reported does not meet any validated criteria, so PS4 is Not Met.
PS3
Functional studies are performed in compound heterozygous patients cells, so PS3 is not applicable.
PS1
No more missense variants that lead to the same amino acid change, so PS1 is Not Met.
PP4
Variant meets PM2, but data reported does not meet any validated criteria, so PS4 is Not Met.
PP1
Segregation data not reported, so PP1 is Not Met.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.